ChemoMetec A/S, based in Denmark, operates in the pharmaceutical industry with a low-risk ESG score of 15.8. Specializing in innovative cell counting and evaluation instruments, the company utilizes patented technology to provide accurate quantitative analysis of various cells in liquids. ChemoMetec's applications include analyzing and counting Mammalian Cells, Yeast Cells, and Sperm Cells, catering to a wide range of industries. With a focus on sustainability and governance, the company offers platforms for determining cell viability, image analysis, and more. Segmented into instruments, consumables, services, and others, ChemoMetec A/S is a leading player in the field of pharmaceutical analytics.